AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Shares Down 0.1% – Should You Sell?

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTALGet Free Report)’s share price was down 0.1% during mid-day trading on Friday . The company traded as low as $19.93 and last traded at $20.05. Approximately 341,197 shares changed hands during mid-day trading, a decline of 28% from the average daily volume of 474,344 shares. The stock had previously closed at $20.08.

AGF U.S. Market Neutral Anti-Beta Fund Stock Down 0.1 %

The business’s 50-day moving average price is $18.87 and its 200 day moving average price is $19.16. The company has a market capitalization of $342.86 million, a P/E ratio of 20.61 and a beta of -0.57.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Creative Financial Designs Inc. ADV increased its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 20.0% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 190,368 shares of the company’s stock worth $3,518,000 after purchasing an additional 31,742 shares during the period. Magnolia Private Wealth LLC purchased a new stake in shares of AGF U.S. Market Neutral Anti-Beta Fund in the 4th quarter valued at about $331,000. Finally, Ethos Financial Group LLC boosted its position in shares of AGF U.S. Market Neutral Anti-Beta Fund by 49.1% during the 4th quarter. Ethos Financial Group LLC now owns 20,225 shares of the company’s stock valued at $386,000 after acquiring an additional 6,663 shares during the last quarter.

About AGF U.S. Market Neutral Anti-Beta Fund

(Get Free Report)

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.

Recommended Stories

Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.